These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 26782096)

  • 1. Virus-based nanoparticles as platform technologies for modern vaccines.
    Lee KL; Twyman RM; Fiering S; Steinmetz NF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):554-78. PubMed ID: 26782096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Label-free detection and manipulation of single biological nanoparticles.
    DeSantis MC; Cheng W
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):717-29. PubMed ID: 26846164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle formulations of cisplatin for cancer therapy.
    Duan X; He C; Kron SJ; Lin W
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):776-91. PubMed ID: 26848041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-Based Nanoparticles as Versatile Nanomachines.
    Koudelka KJ; Pitek AS; Manchester M; Steinmetz NF
    Annu Rev Virol; 2015 Nov; 2(1):379-401. PubMed ID: 26958921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens.
    Fan Y; Moon JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27038091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.
    Lim YH; Tiemann KM; Hunstad DA; Elsabahy M; Wooley KL
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):842-871. PubMed ID: 27016134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward RNA nanoparticle vaccines: synergizing RNA and inorganic nanoparticles to achieve immunopotentiation.
    DeLong RK; Curtis CB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27312869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
    Curtis C; Zhang M; Liao R; Wood T; Nance E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27562224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral chemistry: the chemical functionalization of viral architectures to create new technology.
    Chen Z; Li N; Li S; Dharmarwardana M; Schlimme A; Gassensmith JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):512-34. PubMed ID: 26663821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?
    Fontana F; Liu D; Hirvonen J; Santos HA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27470448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of nanoparticles to deliver immunomodulatory oligonucleotides.
    Klinman DM; Sato T; Shimosato T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):631-7. PubMed ID: 26663867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine approaches to improve cancer immunotherapy.
    Qiu H; Min Y; Rodgers Z; Zhang L; Wang AZ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28296286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted nanoparticles for head and neck cancers: overview and perspectives.
    Zhao Y; Chen H; Chen X; Hollett G; Gu Z; Wu J; Liu X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28387452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide nanostructures in biomedical technology.
    Feyzizarnagh H; Yoon DY; Goltz M; Kim DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):730-43. PubMed ID: 26846352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.
    Kelley WJ; Safari H; Lopez-Cazares G; Eniola-Adefeso O
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):909-926. PubMed ID: 27194461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and regulation of exosome-based therapy products.
    Batrakova EV; Kim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifying the tumor microenvironment using nanoparticle therapeutics.
    Roy A; Li SD
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):891-908. PubMed ID: 27038329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional nanoparticle composites: progress in the use of soft and hard nanoparticles for drug delivery and imaging.
    Sangtani A; Nag OK; Field LD; Breger JC; Delehanty JB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28299903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic plant virology for nanobiotechnology and nanomedicine.
    Steele JFC; Peyret H; Saunders K; Castells-Graells R; Marsian J; Meshcheriakova Y; Lomonossoff GP
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jul; 9(4):. PubMed ID: 28078770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles.
    Selby LI; Cortez-Jugo CM; Such GK; Johnston APR
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28160452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.